Skip to main content
padlock icon - secure page this page is secure

Open Access Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012–2017

Download Article:
 Download
(PDF 193.1 kb)
 

No Abstract

No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Papua New Guinea; Xpert® MTB/RIF; drug susceptibility testing; multidrug-resistant tuberculosis

Document Type: Research Article

Affiliations: 1: Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG) 2: Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG), Health and HIV Implementation Services Provider, Port Moresby, PNG 3: Queensland Mycobacterium Reference Laboratory, Pathology Queensland Central Laboratory at Royal Brisbane Hospital, Brisbane, Queensland, Australia 4: Papua New Guinea National TB Programme, Port Moresby, PNG 5: Burnet Institute, Melbourne, Victoria, Australia 6: Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, New South Wales, Australia 7: Burnet Institute, Melbourne, Victoria, Australia, Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia 8: School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, PNG

Publication date: September 21, 2019

More about this publication?
  • Public Health Action (PHA), The Union's quarterly Open Access journal, welcomes the submission of articles on operational research. It publishes high-quality scientific research on health services, providing new knowledge on how to improve access, equity, quality and efficiency of health systems and services.

    The Editors will consider any manuscript reporting original research on quality improvements, cost-benefit analysis, legislation, training and capacity building, with a focus on all relevant areas of public health (e.g. infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance, outbreaks etc).

  • Editorial Board
  • Information for Authors
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more